Novel chromosomal aberration in Philadelphia negative cells of a patient with chronic myelogenous leukemia treated with dasatinib

Leukemia and Lymphoma

Volumn 49, Issue 5, 2008, Pages 1012-1013

  Athanasiadou, Anastasia ^a   Lalayanni, Chrysavgi ^a   Papaioannou, George ^a   Gaitatzi, Maria ^a   Fassas, Athanasios ^a   Anagnostopoulos, Achilles ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ALPHA INTERFERON; DASATINIB; IMATINIB;

ADULT; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME 7; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; METAPHASE CHROMOSOME; MONOSOMY 7; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TREATMENT RESPONSE; Y CHROMOSOME;

ADULT; CHROMOSOME ABERRATIONS; HUMANS; LEUKEMIA, MYELOID, CHRONIC, ATYPICAL, BCR-ABL NEGATIVE; MALE; PYRIMIDINES; THIAZOLES;

EID: 46749128940     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190801975543     Document Type: Letter

References (9)

1. Fayad, L., Kantarjian, H., O'Brien, S., Seong, D., Albitar, M. and Keating, M. (1997) Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases. Leukemia, 11, pp. 767-771.
2. Bacher, U., Hochhaus, A., Berger, U., Hiddemann, W., Hehlmann, R. and Haferlach, T. (2005) Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon A. Leukemia, 19, pp. 460-463.
3. Andersen, M. K., Pedersen-Bjergaard, J., Kjeldsen, L., Dufva, I. H. and Brondum-Nielsen, K. (2002) Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia, 16, pp. 1390-1393.
4. O'Dwyer, M. E., Gatter, K. M., Loriaux, M., Druker, B. J., Olson, S. B. and Magenis, R. E. (2003) Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukaemia during major cytogenetic responses induced by imatinib mesylate. Leukemia, 17, pp. 481-487.
5. Athanasiadou, A., Stavroyianni, N., Saloum, R., Asteriou, O., Anagnostopoulos, A. and Fassas, A. (2004) Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: Report of three cases. Leukemia, 18, pp. 1029-1031.
6. Lin, Y., Bruyere, H., Horsman, D., Pantzar, T., Barnett, M. and Hogge, D. (2006) Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: A report of nine cases and analysis of predictive factors. Cancer Genet Cytogenet, 170, pp. 16-23.
7. Fabarius, A., Haferlach, C., Moller, M. C., Erben, P., Lahaye, T. and Giehl, M. (2007) Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure. Haematologica, 92, pp. 834-837.
8. Kovitz, C., Kantarjian, H., Garcia-Manero, G., Abruzzo, L. V. and Cortes, J. (2006) Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood, 108, pp. 2811-2813.
9. Jabbour, E., Kantarjian, H. M., Abruzzo, L. V., O'Brien, S., Garcia-Manero, G. and Verstovsek, S. (2007) Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood, 110, pp. 2991-2995.